Literature DB >> 1438670

Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma.

A P Smith1, J Banks, K Buchanan, B Cheong, K A Gunawardena.   

Abstract

Twenty-five patients with acute severe asthma were treated with oxygen, corticosteroids and either salbutamol or aminophylline by intravenous infusion. Blood glucose, plasma insulin and glucagon were measured during the first 24 hours of treatment. Salbutamol and aminophylline rapidly caused hyperglycaemia, accompanied by a rise in insulin and a fall in plasma glucagon. At first the increase in plasma insulin was insufficient to restore normoglycaemia, but by 24 hours homeostasis was restored. The early submaximal insulin response was attributed to the fasting caused by breathlessness. There was no evidence of an increase in hormone secretion caused by direct beta 2-adrenergic stimulation of the pancreatic islets. The effect of corticosteroids on blood glucose over the period of study was considerably less than the contribution of either salbutamol, or aminophylline.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438670

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  5 in total

1.  Extreme stress hyperglycemia during acute illness in a pediatric emergency department.

Authors:  Scott L Weiss; Jamin Alexander; Michael S D Agus
Journal:  Pediatr Emerg Care       Date:  2010-09       Impact factor: 1.454

2.  Estimation of HbA1c in hospitalized patients with bronchial asthma.

Authors:  Bayar Qasim; Safer Haj; Herish Ahmed
Journal:  Endocrine       Date:  2017-09-07       Impact factor: 3.633

3.  Effects of acute salbutamol intake during supramaximal exercise in women.

Authors:  Bénédicte Le Panse; Alexandre Arlettaz; Hugues Portier; Anne-Marie Lecoq; Jacques De Ceaurriz; Katia Collomp
Journal:  Br J Sports Med       Date:  2007-01-30       Impact factor: 13.800

4.  A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study.

Authors:  Heikki O Koskela; Päivi H Salonen; Jarkko Romppanen; Leo Niskanen
Journal:  BMJ Open       Date:  2015-01-29       Impact factor: 2.692

5.  Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Andrew W Hitchings; Dilys Lai; Paul W Jones; Emma H Baker
Journal:  Thorax       Date:  2016-02-25       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.